I have thoroughly read the paper and cross-checked every claim. Let me now produce the consolidated review.

---

## Summary

This paper proposes EffiDPSRecon, an efficient diffusion posterior sampling method for CT reconstruction at reduced radiation doses. The method combines three key components — conjugate gradient (CG) data enhancement on the posterior mean estimate, forward resampling to map the enhanced estimate back to the appropriate noise level, and FBP-based initialization to drastically cut the required sampling steps from 1000 to 50. The primary evidence is that across six dose-reduction scenarios (three low-dose noise levels and three sparse-view settings), EffiDPSRecon achieves the best PSNR/SSIM values while requiring under 10% of the computation time of DPS and MCG.

---

## Strengths

1. **Significant reduction in sampling steps while improving quality**: The method reduces diffusion steps from 1000 to 50, achieving over 10× speedup over DPS/MCG (Table 2), while also improving reconstruction quality (Table 1). This combination of speed *and* quality is the paper's strongest empirical contribution.

2. **Consistent outperformance across diverse dose-reduction scenarios**: The method achieves the highest PSNR and SSIM across all six tested conditions — three LDCT noise levels (Iᵢ = 10⁴, 5×10⁴, 10⁵) and three sparse-view settings (32, 64, 96 views) in Table 1, demonstrating robustness across the test conditions.

3. **Controlled acceleration experiment (Figure 3)**: The paper includes an explicit head-to-head comparison where all diffusion methods use the same reduced step counts (N′=10, 20, 50, 100) and the same FBP initialization. This shows that EffiDPSRecon retains performance whereas DPS and MCG degrade sharply, cleanly attributing the advantage to the algorithmic design rather than simply better initialization or more steps.

4. **Ablation confirms necessity of both CG and forward sampling**: Table 3 shows that removing either the CG projection or the forward resampling step degrades PSNR and SSIM, verifying that both components contribute to the reported gains.

5. **Clear computational cost analysis**: Section 3.2 explicitly compares per-iteration costs (NFE and Radon operations) across DPS, MCG, and EffiDPSRecon, transparently explaining how a higher per-iteration cost is offset by drastically fewer total iterations.

---

## Weaknesses

### Fatal
None.

### Major

- **Missing hyperparameter reporting for the proposed method**: Three critical hyperparameters are introduced but not specified: the step size ρₜ in Equation (17), the noise variance σ² used in the likelihood approximation (Equation 16), and the exact number of CG iterations *k* (only described as "typically set from 2 to 5" but the specific value used in experiments is never stated). Without these values, a practitioner cannot reproduce the results. The paper does specify hyperparameters for baselines (DPS step size, ADMM-TV λ) but omits its own. *Why it matters: This directly impacts reproducibility and practical adoption.*

### Minor

- **Limited ablation scope**: The ablation study (Table 3) tests only two components (CG and forward sampling) on only two conditions (32-view and Iᵢ=10⁴). Several important ablations are missing: (a) the effect of FBP initialization versus starting from pure noise at the same N′; (b) sensitivity to the number of CG iterations *k* on both quality and runtime; (c) sensitivity to the choice of starting timestep N′ (the paper uses N′=50 for all tasks without testing whether other values would perform better for different noise/view conditions). The paper's contribution rests on four components (posterior mean approximation, CG projection, forward resampling, FBP initialization), and the ablation addresses only two.

- **No standard deviations or confidence intervals reported**: Table 1 reports only mean PSNR/SSIM over 50 test images from 2 patients. Without error bars or a statistical test, the reader cannot assess whether differences between methods are significant, especially for conditions where margins are smaller (e.g., LDCT at Iᵢ=10⁵).

- **Ambiguity in the "3.5 dB" improvement claim**: The abstract and introduction state an "average of 3.5 dB" improvement without specifying the baseline (over DPS? over MCG? averaged over both?). Clarifying this would improve transparency.

- **No discussion of failure modes or robustness boundaries**: The paper tests only three dose levels (Iᵢ ≥ 10⁴) and three view counts (≥ 32 views). It does not explore more extreme conditions (e.g., Iᵢ=10³, 16 views) where the method might struggle, which would clarify its practical limits.

- **Missing empirical analysis of the CG projection behavior**: The paper claims CG projection "enhances data consistency" but provides no direct evidence (e.g., data fidelity comparison before/after CG, convergence behavior) beyond the aggregate ablation in Table 3. A simple plot of residual norms would strengthen the claim.

### Trivial
None warrant separate listing beyond the minor points above.

---

## Nice-to-Haves

- A runtime breakdown showing time spent on neural network evaluations vs. Radon transforms vs. CG iterations would increase transparency, though the aggregate 10× speedup already makes the main point.
- A discussion of how the σ² assumption in the likelihood approximation (inherited from DPS) affects behavior at early vs. late timesteps would be informative but is not required for the paper's core contribution.

---

## Removed Points

These points were flagged by reviewers but are removed for the following reasons:

- **"Missing controlled comparison with same steps and initialization"** — Removed because Figure 3 *already provides exactly this comparison*. The reviewer's ask is already in the paper (same N′ values, same FBP initialization across methods).
- **"Missing clinical evaluation / radiologist scoring"** — Removed because this is a computational methods paper, not a clinical trial. Evaluating with PSNR/SSIM on standard benchmarks is appropriate for its class.
- **"Missing comparison to DDNM/latent diffusion / other accelerated methods"** — Removed because the paper already compares against DPS and MCG, which are the direct method-level baselines. Demanding comparisons against every related approach is scope creep, and some referenced methods cannot be verified as existing.
- **"Figure 2 caption clarity"** — Removed as a minor presentation nitpick that does not affect the technical contribution.
- **Generic strengths from Strength Finder about "important problem"** — Removed as superficial; only specific, cited strengths are retained.

---

## Novel Insights

None beyond the paper's own contributions. The reviews do not surface a perspective that the paper itself does not provide or imply.

---

## Suggestions

1. **Report all missing hyperparameters**: Specify the exact ρₜ value (or schedule), the σ² value used in the likelihood approximation, and the specific *k* value used for CG in the main experiments.
2. **Complete the ablation**: Add an ablation comparing FBP-init vs. pure-noise starting point at the same N′, and show PSNR vs. *k* and PSNR vs. N′ sensitivity curves for at least one representative condition.
3. **Report standard deviations** for all entries in Table 1 to enable readers to assess statistical significance.
4. **Clarify the "3.5 dB" claim** by explicitly stating the baseline(s) over which this average is computed.
5. **Add a failure-mode discussion** or test at least one more extreme condition (e.g., 16 views or Iᵢ=10³) to bound the method's operating range.

---

## Score and Decision

The paper presents a practically useful method that demonstrably accelerates diffusion-based CT reconstruction while improving quality. The controlled experiment (Figure 3) cleanly separates the method's contribution from confounding factors. The weaknesses — missing hyperparameters, incomplete ablation, and absent error bars — are real but fixable and do not invalidate the core claims. With reasonable revisions (particularly reporting hyperparameters and completing the ablation), this paper would be a solid contribution.

MY FINAL SCORE: <pineapple>6.0</pineapple>
MY FINAL DECISION: <orange>Accept</orange>